Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model.

Research output: Contribution to journalReview articlepeer-review

115 Scopus citations


OBJECTIVE: To review the evidence for and against the role of visceral adipose tissue as a major contributor to the metabolic complications of obesity through abnormal regulation of lipolysis. RESEARCH METHODS AND PROCEDURES: Data from investigators in the field who have studied visceral adiposity and metabolic health and/or regional and systemic free fatty acid (FFA) release were considered. RESULTS: Although visceral fat mass was positively correlated with adverse health consequences and excess FFA availability, visceral fat was not the source of excess systemic FFA availability. Upper body non-visceral fat contributes the majority of FFAs in lean, obese, diabetic, and non-diabetic humans. Increasing amounts of visceral fat probably result in greater hepatic FFA delivery. DISCUSSION: Systemic, as opposed to hepatic, insulin resistance is unlikely to be caused by high rates of visceral adipose tissue lipolysis.

Original languageEnglish (US)
Pages (from-to)20S-24S
JournalObesity (Silver Spring, Md.)
Volume14 Suppl 1
StatePublished - Feb 2006

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Nutrition and Dietetics


Dive into the research topics of 'Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model.'. Together they form a unique fingerprint.

Cite this